InsiderDB

Follow the company. Check the evidence.

Public records connected to stocks traded by Congress. See what changed, when it became public, and the original source.

Clear
  1. VTRSLobbying report·Lobbying disclosures

    VTRS: third_quarter 2026 lobbying report

    S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S. 2658, The Medication Affordability and Patent Integrity Act IP Issues related to generic medicines Patent Settlements Trade issues related to generic medicines Pharmaceutical supply chain S.3778: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act S.3841: Last Sale Valuation Act Policy related to corporate

    Public: Oct 20, 2026, 8:43 PM EDTOriginal source ↗
  2. VTRSLobbying report·Lobbying disclosures

    VTRS: third_quarter 2026 lobbying report

    Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071). Trade issues related to generic medicines.

    Public: Oct 19, 2026, 4:20 PM EDTOriginal source ↗
  3. VTRSLobbying report·Lobbying disclosures

    VTRS: third_quarter 2026 lobbying report

    S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; Drug Shortages; Medicaid Generics Penalty.

    Public: Oct 7, 2026, 6:43 AM EDTOriginal source ↗
  4. VTRSLobbying report·Lobbying disclosures

    VTRS: second_quarter 2026 lobbying report

    S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S. 2658, The Medication Affordability and Patent Integrity Act IP Issues related to generic medicines Patent Settlements Trade issues related to generic medicines Pharmaceutical supply chain S.3778: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act S.3841: Last Sale Valuation Act Policy related to corporate

    Public: Jul 20, 2026, 8:26 PM EDTOriginal source ↗
  5. VTRSLobbying report·Lobbying disclosures

    VTRS: second_quarter 2026 lobbying report

    Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071). Trade issues related to generic medicines.

    Public: Jul 20, 2026, 2:51 PM EDTOriginal source ↗
  6. VTRSLobbying report·Lobbying disclosures

    VTRS: second_quarter 2026 lobbying report

    S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.

    Public: Jul 13, 2026, 7:51 AM EDTOriginal source ↗

Connections describe public records, not evidence of wrongdoing or a prediction of returns. Event dates can precede publication by days or months. When a source has no public-release timestamp, we show when we first observed it.

Source coverage

Coverage is growing across companies already tracked here. A scan can return no matching records. This feed is not a complete record of every filing or agency action.

SEC EDGAR
Current across tracked companies505 of 505 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:06 PM EST
USAspending
Collection in progress76 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:06 PM EST
SAM.gov
Awaiting company connections
Lobbying disclosures
Not yet scanned0 of 548 companies scanned in the past 12 hours
Congress.gov
Current across tracked companies5 of 5 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 12:27 PM EST
Federal Register
Stale — refresh overdue297 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:06 PM EST
Regulations.gov
Partial coverage — some requests unavailable31 of 53 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:00 PM EST
FEC campaign finance
Stale — refresh overdue0 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 11, 2026, 1:28 PM EST